Lack of Association Between MAGEL2 and Schizophrenia and Mood Disorders in the Japanese Population
详细信息 查看全文
- 作者：Yasuhisa Fukuo (1)
Taro Kishi (1)
Tomo Okochi (1)
Tsuyoshi Kitajima (1)
Tomoko Tsunoka (1)
Takenori Okumukura (1)
Yoko Kinoshita (1)
Kunihiro Kawashima (1)
Yoshio Yamanouchi (1)
Wakako Umene-Nakano (2)
Hiroshi Naitoh (1)
Toshiya Inada (3)
Reiji Yoshimura (2)
Jun Nakamura (2)
Norio Ozaki (4)
Nakao Iwata (1) - 关键词：Major depressive disorder ; Bipolar disorder ; Schizophrenia ; MAGEL2 ; Linkage disequilibrium ; Tagging SNP
- 刊名：NeuroMolecular Medicine
- 出版年：2010
- 出版时间：September 2010
- 年：2010
- 卷：12
- 期：3
- 页码：285-291
- 全文大小：237KB
- 参考文献：1. Abe, O., Yamasue, H., Kasai, K., Yamada, H., Aoki, S., Inoue, H., et al. (2010). Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. / Psychiatry Research, / 181(1), 64-0. CrossRef
2. Barbini, B., Benedetti, F., Colombo, C., Guglielmo, E., Campori, E., & Smeraldi, E. (1998). Perceived mood and skin body temperature rhythm in depression. / European Archives of Psychiatry and Clinical Neuroscience, / 248(3), 157-60. CrossRef
3. Barnard, A. R., & Nolan, P. M. (2008). When clocks go bad: neurobehavioural consequences of disrupted circadian timing. / PLoS Genet, / 4(5), e1000040. CrossRef
4. Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005). Haploview: analysis and visualization of LD and haplotype maps. / Bioinformatics, / 21(2), 263-65. CrossRef
5. Berk, M., Dodd, S., Kauer-Sant’anna, M., Malhi, G. S., Bourin, M., Kapczinski, F., et al. (2007). Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. / Acta Psychiatrica Scandinavica. Supplementum, / 434, 41-9. CrossRef
6. Bischof, J. M., Stewart, C. L., & Wevrick, R. (2007). Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome. / Human Molecular Genetics, / 16(22), 2713-719. CrossRef
7. Bora, E., Yucel, M., & Allen, N. B. (2009). Neurobiology of human affiliative behaviour: Implications for psychiatric disorders. / Current Opinion in Psychiatry, / 22(3), 320-25. CrossRef
8. Bowden, C. L. (2001). Strategies to reduce misdiagnosis of bipolar depression. / Psychiatric Services, / 52(1), 51-5. CrossRef
9. Brambilla, P., Hatch, J. P., & Soares, J. C. (2008). Limbic changes identified by imaging in bipolar patients. / Current Psychiatry Reports, / 10(6), 505-09. CrossRef
10. Brunet-Gouet, E., & Decety, J. (2006). Social brain dysfunctions in schizophrenia: a review of neuroimaging studies. / Psychiatry Research, / 148(2-), 75-2. CrossRef
11. Depienne, C., Moreno-De-Luca, D., Heron, D., Bouteiller, D., Gennetier, A., Delorme, R., et al. (2009). Screening for genomic rearrangements and methylation abnormalities of the 15q11–q13 region in autism spectrum disorders. / Biological Psychiatry, / 66(4), 349-59. CrossRef
12. Dudbridge, F. (2003). Pedigree disequilibrium tests for multilocus haplotypes. / Genetic Epidemiology, / 25(2), 115-21. CrossRef
13. Feng, Y., Vetro, A., Kiss, E., Kapornai, K., Daroczi, G., Mayer, L., et al. (2008). Association of the neurotrophic tyrosine kinase receptor 3 (NTRK3) gene and childhood-onset mood disorders. / American Journal of Psychiatry, / 165(5), 610-16. CrossRef
14. Hogart, A., Wu, D., Lasalle, J. M., & Schanen, N. C. (2008). The comorbidity of autism with the genomic disorders of chromosome 15q11.2–q13. / Neurobiology of Disease, / 38(2), 181-91. CrossRef
15. Ikeda, M., Aleksic, B., Kirov, G., Kinoshita, Y., Yamanouchi, Y., Kitajima, T., et al. (2009). Copy number variation in schizophrenia in the Japanese population. / Biological Psychiatry, / 67(3), 283-86. CrossRef
16. Kanber, D., Giltay, J., Wieczorek, D., Zogel, C., Hochstenbach, R., Caliebe, A., et al. (2009). A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader-Willi syndrome. / European Journal of Human Genetics, / 17(5), 582-90. CrossRef
17. Kim, S. J., Brune, C. W., Kistner, E. O., Christian, S. L., Courchesne, E. H., Cox, N. J., et al. (2008). Transmission disequilibrium testing of the chromosome 15q11–q13 region in autism. / American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, / 147B(7), 1116-125. CrossRef
18. Kishi, T., Kitajima, T., Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., et al. (2008). Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population. / Neuroscience Research, / 62(4), 211-15. CrossRef
19. Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., et al. (2009a). Association analysis of functional polymorphism in estrogen receptor alpha gene with schizophrenia and mood disorders in the Japanese population. / Psychiatric Genetics, / 19(4), 217-18. CrossRef
20. Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., et al. (2009b). A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis. / Progress in Neuro-Psychopharmacology and Biological Psychiatry, / 33(5), 895-98. CrossRef
21. Kishi, T., Kitajima, T., Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., et al. (2009c). Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population. / European Archives of Psychiatry and Clinical Neuroscience, / 259(5), 293-97. CrossRef
22. Kishi, T., Kitajima, T., Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., et al. (2009d). CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients. / Neuromolecular Medicine, / 11(2), 53-7. CrossRef
23. Kishi, T., Kitajima, T., Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., et al. (2009e). Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population. / Neuropsychobiology, / 59(4), 234-38. CrossRef
24. Kishi, T., Kitajima, T., Tsunoka, T., Ikeda, M., Yamanouchi, Y., Kinoshita, Y., et al. (2009f). Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population. / Neuroscience Research, / 64(2), 231-34. CrossRef
25. Kishi, T., Kitajima, T., Tsunoka, T., Okumura, T., Ikeda, M., Okochi, T., et al. (2009g). Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population. / Neuromolecular Medicine, / 11(2), 114-22. CrossRef
26. Kishi, T., Tsunoka, T., Ikeda, M., Kawashima, K., Okochi, T., Kitajima, T., et al. (2009h). Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. / Journal of Human Genetics, / 54(11), 629-33. CrossRef
27. Kishi, T., Yoshimura, R., Kitajima, T., Okochi, T., Okumura, T., Tsunoka, T., et al. (2009i). HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort. / Neuromolecular Medicine, in press.
28. Kishi, T., Tsunoka, T., Ikeda, M., Kitajima, T., Kawashima, K., Okochi, T., et al. (2010). Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. / Neuropharmacology, / 58(2), 452-56. CrossRef
29. Konarski, J. Z., McIntyre, R. S., Kennedy, S. H., Rafi-Tari, S., Soczynska, J. K., & Ketter, T. A. (2008). Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. / Bipolar Disorders, / 10(1), 1-7. CrossRef
30. Kozlov, S. V., Bogenpohl, J. W., Howell, M. P., Wevrick, R., Panda, S., Hogenesch, J. B., et al. (2007). The imprinted gene Magel2 regulates normal circadian output. / Nature Genetics, / 39(10), 1266-272. CrossRef
31. Lang, U. E., Puls, I., Muller, D. J., Strutz-Seebohm, N., & Gallinat, J. (2007). Molecular mechanisms of schizophrenia. / Cellular Physiology and Biochemistry, / 20(6), 687-02. CrossRef
32. Maier, W., Hofgen, B., Zobel, A., & Rietschel, M. (2005). Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes? / European Archives of Psychiatry and Clinical Neuroscience, / 255(3), 159-66. CrossRef
33. Mansour, H. A., Talkowski, M. E., Wood, J., Chowdari, K. V., McClain, L., Prasad, K., et al. (2009). Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. / Bipolar Disorders, / 11(7), 701-10. CrossRef
34. Mansour, H. A., Wood, J., Logue, T., Chowdari, K. V., Dayal, M., Kupfer, D. J., et al. (2006). Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. / Genes, Brain, and Behavior, / 5(2), 150-57. CrossRef
35. McClung, C. A. (2007a). Circadian genes, rhythms and the biology of mood disorders. / Pharmacology and Therapeutics, / 114(2), 222-32. CrossRef
36. McClung, C. A. (2007b). Circadian rhythms, the mesolimbic dopaminergic circuit, and drug addiction. / Scientific World Journal, / 7, 194-02.
37. McClung, C. A. (2007c). Clock genes and bipolar disorder: Implications for therapy. / Pharmacogenomics, / 8(9), 1097-100. CrossRef
38. McClung, C. A. (2007d). Role for the Clock gene in bipolar disorder. / Cold Spring Harbor Symposia on Quantitative Biology, / 72, 637-44. CrossRef
39. Mercer, R. E., Kwolek, E. M., Bischof, J. M., van Eede, M., Henkelman, R. M., & Wevrick, R. (2009). Regionally reduced brain volume, altered serotonin neurochemistry, and abnormal behavior in mice null for the circadian rhythm output gene Magel2. / American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, / 150B(8), 1085-099. CrossRef
40. Muller, N., & Schwarz, M. J. (2008). A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: Schizophrenia and major depression as inflammatory CNS disorders. / European Archives of Psychiatry and Clinical Neuroscience, / 258(Suppl 2), 97-06. CrossRef
41. Nestler, E. J., & Carlezon, W. A., Jr. (2006). The mesolimbic dopamine reward circuit in depression. / Biological Psychiatry, / 59(12), 1151-159. CrossRef
42. Nievergelt, C. M., Kripke, D. F., Barrett, T. B., Burg, E., Remick, R. A., Sadovnick, A. D., et al. (2006). Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. / American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, / 141B(3), 234-41. CrossRef
43. Otnaess, M. K., Djurovic, S., Rimol, L. M., Kulle, B., Kahler, A. K., Jonsson, E. G., et al. (2009). Evidence for a possible association of neurotrophin receptor (NTRK-3) gene polymorphisms with hippocampal function and schizophrenia. / Neurobiology of Diseases, / 34(3), 518-24. CrossRef
44. Purcell, S., Cherny, S. S., & Sham, P. C. (2003). Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. / Bioinformatics, / 19(1), 149-50. CrossRef
45. Savitz, J., Nugent, A. C., Bogers, W., Liu, A., Sills, R., Luckenbaugh, D. A., et al. (2010). Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication. / Neuroimage, / 49(4), 2966-976. CrossRef
46. Severino, G., Manchia, M., Contu, P., Squassina, A., Lampus, S., Ardau, R., et al. (2009). Association study in a Sardinian sample between bipolar disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system. / Bipolar Disorders, / 11(2), 215-20. CrossRef
47. Soni, S., Whittington, J., Holland, A. J., Webb, T., Maina, E., Boer, H., et al. (2007). The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment. / Journal of Intellectual Disability Research, / 51(Pt 1), 32-2. CrossRef
48. Soni, S., Whittington, J., Holland, A. J., Webb, T., Maina, E. N., Boer, H., et al. (2008). The phenomenology and diagnosis of psychiatric illness in people with Prader-Willi syndrome. / Psychological Medicine, / 38(10), 1505-514. CrossRef
49. Soria, V., Martinez-Amoros, E., Escaramis, G., Valero, J., Perez-Egea, R., Garcia, C., et al. (2010). Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. / Neuropsychopharmacology, / 35(6), 1279-289. CrossRef
50. Stefansson, H., Rujescu, D., Cichon, S., Pietilainen, O. P., Ingason, A., Steinberg, S., et al. (2008). Large recurrent microdeletions associated with schizophrenia. / Nature, / 455(7210), 232-36. CrossRef
51. Stensland, M. D., Schultz, J. F., & Frytak, J. R. (2008). Diagnosis of unipolar depression following initial identification of bipolar disorder: a common and costly misdiagnosis. / Journal of Clinical Psychiatry, / 69(5), 749-58. CrossRef
52. van der Zwaag, B., Staal, W. G., Hochstenbach, R., Poot, M., Spierenburg, H. A., de Jonge, M. V., et al. (2009). A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder. / American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, in press.
53. Verma, R., Holmans, P., Knowles, J. A., Grover, D., Evgrafov, O. V., Crowe, R. R., et al. (2008). Linkage disequilibrium mapping of a chromosome 15q25-6 major depression linkage region and sequencing of NTRK3. / Biological Psychiatry, / 63(12), 1185-189. CrossRef
54. Voderholzer, U., Riemann, D., Huwig-Poppe, C., Kuelz, A. K., Kordon, A., Bruestle, K., et al. (2007). Sleep in obsessive compulsive disorder: polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency. / European Archives of Psychiatry and Clinical Neuroscience, / 257(3), 173-82. CrossRef
55. Williams, J. B. (1988). A structured interview guide for the Hamilton Depression Rating Scale. / Archives of General Psychiatry, / 45(8), 742-47.
56. Yamaguchi-Kabata, Y., Nakazono, K., Takahashi, A., Saito, S., Hosono, N., Kubo, M., et al. (2008). Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. / American Journal of Human Genetics, / 83(4), 445-56. CrossRef
57. Yang, Y., Raine, A., Han, C. B., Schug, R. A., Toga, A. W., & Narr, K. L. (2010). Reduced hippocampal and parahippocampal volumes in murderers with schizophrenia. / Psychiatry Research, / 182(1), 9-3. CrossRef - 作者单位：Yasuhisa Fukuo (1)
Taro Kishi (1)
Tomo Okochi (1)
Tsuyoshi Kitajima (1)
Tomoko Tsunoka (1)
Takenori Okumukura (1)
Yoko Kinoshita (1)
Kunihiro Kawashima (1)
Yoshio Yamanouchi (1)
Wakako Umene-Nakano (2)
Hiroshi Naitoh (1)
Toshiya Inada (3)
Reiji Yoshimura (2)
Jun Nakamura (2)
Norio Ozaki (4)
Nakao Iwata (1)
1. Department of Pychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, 470-1192, Japan
2. Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, 807-8555, Japan
3. Neuropsychiatric Research Institute, Seiwa Hospital, Tokyo, 162-0851, Japan
4. Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, 466-8850, Japan
文摘
Several investigations have reported that abnormalities in circadian rhythms might be related with the pathophysiology of psychiatric disorders, since many psychiatric patients have insomnia and sleep-awake disturbance. A recent animal study reported that Magel2, which encodes a member of the MAGE/necdin family of proteins, might be associated in the pathophysiology of psychiatric disorders. Magel2 gene knockout mice showed altered concentrations of both dopamine and serotonin in several parts of the brain compared with controls. In addition, the authors of that study detected a bilateral reduction in cortical volume in distinct regions of the Magel2 gene knockout mice brain, including focused regions in the parieto-temporal lobe of the cerebral cortex, the amygdala, the hippocampus, and the nucleus accumbens. These mice were also found to have hypoactivity and abnormalities in circadian rhythms. From this evidence, we considered Magel2 gene (MAGEL2) to be a good candidate gene for the pathophysiology of schizophrenia and mood disorder, and we conducted a case–control study among Japanese (731 schizophrenia patients, 465 MDD patients, 156 BP patients and 758 controls) using three tagging SNPs in MAGEL2 (rs850815, rs8920 and rs4480754), selected using the HapMap database. We did not find any association between MAGEL2 and schizophrenia, BP or MDD in allele/genotype-wise analysis or haplotype-wise analysis. Our results suggest that MAGEL2 may not play a role in the pathophysiology of schizophrenia and mood disorders in the Japanese population. A replication study using larger samples may be required for conclusive results, since our sample size was small and our study analyzed only three SNPs in MAGEL2.